Parallel Industries Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EAPH research report →
Companywww.eastonpharma.com
Parallel Industries Inc. does not have significant operations. Previously, the company was involved in development and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions.
- CEO
- Evan Karras
- IPO
- 1999
- Employees
- 6
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $18.66K
- P/E
- -0.14
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 2784281.81
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -2.70%
- ROIC
- -1.97%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-189,000 · 41.49%
- EPS
- $-0.00 · 50.00%
- Op Income
- $-189,000
- FCF YoY
- -142.15%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 27.13
- Avg Volume
- 16
Get TickerSpark's AI analysis on EAPH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EAPH Coverage
We haven't published any research on EAPH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EAPH Report →